---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-143187"
form_type: "8-K"
ticker: "ANTX"
cik: "0001880438"
company_name: "AN2 Therapeutics, Inc."
filed_at: "2025-06-20T23:59:59+00:00"
generated_at: "2026-05-19T01:55:42.587581+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# AN2 Therapeutics exchanges 2.8M common shares for pre-funded warrants with Coastlands Capital

## Summary
- Exchanged 2,500,000 shares of common stock for pre-funded warrant for 2,500,000 shares on June 17, 2025.
- Exchanged additional 300,000 shares for pre-funded warrant for 300,000 shares on June 19, 2025.
- Warrants have $0.00001 exercise price, no expiration, and beneficial ownership blocker at 9.99% (up to 19.99%).
- Issued under Section 3(a)(9) exemption from registration; form of warrant filed as Exhibit 4.1.

## SEC filing metadata
- accession: 0001193125-25-143187
- form_type: 8-K
- ticker: ANTX
- cik: 0001880438
- company_name: AN2 Therapeutics, Inc.
- filed_at: 2025-06-20T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1880438/000119312525143187/0001193125-25-143187-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1880438/000119312525143187/d50241d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-143187
- JSON: https://secwatch.observer/filing/0001193125-25-143187.json
- Plain text: https://secwatch.observer/filing/0001193125-25-143187.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.